Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sana Biotechnology (SANA) just unveiled an announcement.
Douglas Williams, Ph.D., has voluntarily resigned from his roles as Executive Vice President and President of Research and Development at Sana Biotechnology, Inc., effective April 18, 2024. His departure is for personal reasons and does not stem from any disputes with the company.
See more insights into SANA stock on TipRanks’ Stock Analysis page.